Results 291 to 300 of about 625,224 (357)

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment. [PDF]

J Exp Clin Cancer Res
Smith EA, Belote RL, Cruz NM, Moustafa TE, Becker CA, Jiang A, Alizada S, Prokofyeva A, Chan TY, Seasor TA, Balatico M, Cortes-Sanchez E, Lum DH, Hyngstrom JR, Zeng H, Deacon DC, Grossmann AH, White RM, Zangle TA, Judson-Torres RL.   +19 more
europepmc   +1 more source

Immune Checkpoint Inhibitors in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Resistant Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer: A Meta-Analysis Based on Eight Randomized Trials. [PDF]

JCO Precis Oncol
Huang L, Zhang S, Sun L, Ma J, Han C.
europepmc   +1 more source

Structural basis for the transmembrane signaling and antidepressant-induced activation of the receptor tyrosine kinase TrkB. [PDF]

Nat Commun
Kot EF, Goncharuk SA, Franco ML, McKenzie DM, Arseniev AS, Benito-Martínez A, Costa M, Cattaneo A, Hristova K, Vilar M, Mineev KS.   +10 more
europepmc   +1 more source

Anti-cancer activity of EGF receptor-tyrosine kinase inhibitors in human non-small lung cancer cells

, 2013
Ho Viet Anh
openalex   +1 more source

A Targetable Receptor Tyrosine Kinase in Metastatic Pheochromocytoma and Paraganglioma: A Future Journey for Anlotinib? [PDF]

J Endocr Soc
Alkaissi H, Pacak K.
europepmc   +1 more source

Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in <i>EGFR-</i>mutated non-small cell lung cancer: systematic review and network meta-analysis.

BMJ
Ma Z, Cao F, Liao M, Min R, Zheng R, Sun X, Chen X, Gong Y, Ai S, Kang X.   +9 more
europepmc   +1 more source

Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression [Retraction]. [PDF]

Onco Targets Ther
europepmc   +1 more source

Investigation of receptor association and tyrosine phosphorylation of S6 kinases

, 2004
Heike Rebholz
openalex   +1 more source